These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11463510)

  • 1. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers.
    Levy RH; Ragueneau-Majlessi I; Baltes E
    Epilepsy Res; 2001 Aug; 46(2):93-9. PubMed ID: 11463510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
    Ragueneau-Majlessi I; Levy RH; Meyerhoff C
    Epilepsy Res; 2001 Nov; 47(1-2):55-63. PubMed ID: 11673021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
    Coupez R; Nicolas JM; Browne TR
    Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration.
    Toublanc N; Okagaki T; Boyce M; Chan R; Mugitani A; Watanabe S; Yamamoto K; Yoshida K; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):461-9. PubMed ID: 25283522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.
    Cawello W; Mueller-Voessing C; Andreas JO
    Clin Drug Investig; 2014 May; 34(5):327-34. PubMed ID: 24634110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
    Smulders RA; Kuipers ME; Krauwinkel WJ
    Br J Clin Pharmacol; 2006 Aug; 62(2):210-7. PubMed ID: 16842396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects.
    Zhao Q; Jiang J; Li X; Lu ZS; Hu P
    Br J Clin Pharmacol; 2007 May; 63(5):614-7. PubMed ID: 17324224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.
    Vousden M; Allen A; Lewis A; Ehren N
    Chemotherapy; 1999; 45(6):485-90. PubMed ID: 10567779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
    Stodieck S; Steinhoff BJ; Kolmsee S; van Rijckevorsel K
    Seizure; 2001 Dec; 10(8):583-7. PubMed ID: 11792161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy.
    Bell C; Vanderlinden H; Hiersemenzel R; Otoul C; Nutt D; Wilson S
    J Sleep Res; 2002 Sep; 11(3):255-63. PubMed ID: 12220322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
    Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
    Kadokura T; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary efficacy of levetiracetam in children.
    Glauser TA; Dulac O
    Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.